FORMULATION AND EVALUATION OF BILAYER TABLET OF CONVENTIONAL RELEASE PARACETAMOL AND MODIFIED RELEASE DICLOFENAC SODIUM
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 5
Abstract
The present study deals with formulation and evaluation of bilayer tablet of paracetamol and diclofenac sodium to provide control over release of drug and to maintain the drug concentration. The major ingredients are paracetamol granules and diclofenac sodium granules and were prepared separately by wet granulation method. Paracetamol, PEG6000 and intragranular fraction granules were cooled and blended with microcrystalline cellulose, croscarmellose, Cab-O-Sil and magnesium stearate and mixture of diclofenac sodium and HPMC K4M were granulated using water and isopropyl alcohol. The wet mass is passed through a 20# sieve and dried. The granules of optimized batch of paracetamol and diclofenac sodium were compressed to obtain bi-layer tablet. The tablets were evaluated for percentage friability, crushing strength and in-vitro drug release. Totally 9 formulations for paracetamol and 6 formulations of diclofenac were prepared and studied for their various precompression and postcompression parameters. The formulation F9 for paracetamol showed in-vitro drug release of 93.09% and exhibited satisfactory results in all parameters and subjected to stability studies. And the formulation F6 showed in-vitro drug release of 71.68% and exhibited satisfactory results and was subjected to stability studies. Thus formulation F9 for paracetamol and F6 for Diclofenac was found to be successful as immediate release and extended release bi-layer tablet and can be manufactured with reproducible characteristics from batch to batch.
Authors and Affiliations
Indhumathi D, Mastan Vali Sheik, Priyadharshini N, Damodharan N
Keywords
Related Articles
- EP ID EP33126
- DOI -
- Views 296
- Downloads 1
The curious case of prion proteins:Are they a friend or foe? A review & perspective
Transmissible spongiform encephalopathies (TSE) in humans were known to be caused by prion proteins (PrPC). Recent research has although revealed that prions are an enigmatic protein & their identity holds much more th...
Formulation and evaluation sustained release matrix tablets of Propranol hydrochloride
Propranolol hydrochloride is the most recently a non-selective beta-adrenergic blocking agent, has been widely used in the treatment of hypertension, angina pectoris, phaeochromocytoma, cardiac arrhythmias and other ca...
Formulation and evaluation of mucoadhesive tablet of Clarithromycin
The present investigation concerns the development of mucoadhesive tablets of Clarithromycin which were designed to prolong the gastric residence time after oral administration. Matrix tablets of Clarithromycin were fo...
STABILITY INDICATING HPLC METHOD FOR THE ESTIMATION OF CINACALCET HYDROCHLORIDE API
A stability-indicating liquid chromatography method has been developed and validated for the determination of Cinacalcet hydrochloride in a laboratory mixture as well as in a tablet formulation developed in-house. Effi...
Formulation and evaluation of Diclofenac potassium transdermal patches for enhanced therapeutic efficacy
Today 74% of the drugs are taken orally and are found not to be safe or effective as desired because they produce wide ranging fluctuation in drug concentration in blood stream. Continuous I.V infusion is recognized as...